Truist Securities analysts reiterated a Buy rating on Boston Scientific Corporation (NYSE:BSX) on February 05, 2026. Boston Scientific Corporation operates in the Healthcare…
Truist Securities analysts reiterated a Buy rating on Boston Scientific Corporation (NYSE:BSX) on February 05, 2026.
Boston Scientific Corporation operates in the Healthcare sector. The stock currently trades at $77.64 with a market capitalization of $136.0B.
Current market data
NYSE · BSX
$43.92
Down: -$0.28 · -0.63%
Live quote updated
Keep reading
insider ·
insider ·
institutional ·
sec_filing ·
